NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and CFO Glenn Goddard sold $627K of Intellia Therapeutics, Inc.
Sold$627,178
$180.12Price
3,482Shares
−100%Stake
What NTLA did after the filing
- The stock from Thu, Sep 9 close, $160.81
- −16.5%
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Oct 21 close.
Traded Tue, Sep 7. Filed Thu, Sep 9, 1:38 PM ET, during the session. Returns use the Sep 9 close and the Oct 21 close. Not investment advice.